Total Payments
$7,640
2024 Payments
$1,329
Companies
69
Transactions
459
Medicare Patients
1,656
Medicare Billing
$280,213
Payment Breakdown by Category
Food & Beverage$7,406 (96.9%)
Education$234.41 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,406 | 436 | 96.9% |
| Education | $234.41 | 23 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $584.41 | 47 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $526.65 | 31 | $0 (2024) |
| Genentech USA, Inc. | $449.91 | 29 | $0 (2024) |
| Janssen Biotech, Inc. | $445.71 | 28 | $0 (2024) |
| Merck Sharp & Dohme LLC | $343.29 | 24 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $292.61 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $279.79 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $271.33 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $259.13 | 17 | $0 (2024) |
| PFIZER INC. | $251.27 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,329 | 62 | Novartis Pharmaceuticals Corporation ($154.84) |
| 2023 | $1,128 | 57 | Janssen Biotech, Inc. ($78.93) |
| 2022 | $626.44 | 37 | Pharmacyclics LLC, an AbbVie Company ($71.70) |
| 2020 | $286.67 | 18 | Janssen Biotech, Inc. ($42.99) |
| 2019 | $1,475 | 99 | Celgene Corporation ($178.07) |
| 2018 | $1,470 | 97 | Takeda Pharmaceuticals U.S.A., Inc. ($153.35) |
| 2017 | $1,325 | 89 | Genentech USA, Inc. ($148.95) |
All Payment Transactions
459 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Oncology | ||||||
| 12/28/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Oncology | ||||||
| 12/23/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.94 | General |
| Category: Hematology | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Oncology | ||||||
| 11/22/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Oncology | ||||||
| 11/09/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $24.99 | General |
| 10/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/15/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 08/14/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 357 | 796 | $172,330 | $61,084 |
| 2022 | 6 | 413 | 970 | $206,178 | $75,284 |
| 2021 | 6 | 436 | 1,020 | $203,991 | $81,882 |
| 2020 | 7 | 450 | 921 | $175,221 | $61,963 |
Total Patients
1,656
Total Services
3,707
Medicare Billing
$280,213
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 168 | 471 | $94,230 | $31,812 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 69 | 139 | $37,391 | $14,370 | 38.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 50 | $10,650 | $4,617 | 43.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $9,906 | $3,471 | 35.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 18 | $7,137 | $2,411 | 33.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 36 | $5,400 | $2,210 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 42 | 56 | $7,616 | $2,194 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 208 | 630 | $121,590 | $43,042 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 65 | 97 | $25,123 | $10,769 | 42.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 112 | $22,960 | $8,916 | 38.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 52 | 52 | $19,136 | $6,756 | 35.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 26 | $10,426 | $3,709 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 36 | 53 | $6,943 | $2,092 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 223 | 696 | $126,616 | $50,148 | 39.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 40 | 121 | $23,382 | $9,829 | 42.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 43 | 50 | $18,582 | $7,915 | 42.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 53 | 62 | $15,056 | $6,741 | 44.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 41 | 41 | $14,093 | $5,352 | 38.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 36 | 50 | $6,262 | $1,898 | 30.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 191 | 561 | $97,405 | $31,784 | 32.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 42 | 50 | $17,750 | $7,948 | 44.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 54 | 82 | $19,266 | $6,985 | 36.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 36 | 81 | $14,742 | $6,706 | 45.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 43 | 43 | $14,437 | $5,131 | 35.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 73 | 93 | $11,159 | $3,187 | 28.6% |
About Dr. Bryan Faller, MD
Dr. Bryan Faller, MD is a Hematology & Oncology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790870178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Faller, MD has received a total of $7,640 in payments from pharmaceutical and medical device companies, with $1,329 received in 2024. These payments were reported across 459 transactions from 69 companies. The most common payment nature is "Food and Beverage" ($7,406).
As a Medicare-enrolled provider, Faller has provided services to 1,656 Medicare beneficiaries, totaling 3,707 services with total Medicare billing of $280,213. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Saint Louis, MO
- Active Since 10/03/2006
- Last Updated 10/29/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1790870178
Products in Payments
- KEYTRUDA (Biological) $320.76
- IMBRUVICA (Drug) $308.94
- GILOTRIF (Drug) $279.79
- OPDIVO (Biological) $196.18
- Revlimid (Drug) $186.80
- DARZALEX (Biological) $185.84
- Pomalyst (Drug) $179.70
- KISQALI (Drug) $170.29
- LIBTAYO (Biological) $160.50
- CYRAMZA (Drug) $148.27
- TAGRISSO (Drug) $129.80
- Cabometyx (Drug) $123.40
- Abraxane (Drug) $112.69
- JAKAFI (Drug) $109.43
- Avastin (Biological) $105.44
- Bavencio (Biological) $99.45
- BRUKINSA (Drug) $97.40
- Aliqopa (Drug) $94.59
- Venclexta (Drug) $86.39
- IBRANCE (Drug) $85.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Saint Louis
Maurice Willis, Md, MD
Hematology & Oncology — Payments: $77,431
Hematology & Oncology $77,431
Dr. Geoffrey Uy, Md, MD
Hematology & Oncology — Payments: $29,892
Hematology & Oncology $29,892
Dr. Jason Li, Md, MD
Hematology & Oncology — Payments: $22,919
Hematology & Oncology $22,919
John Finnie, Md, MD
Hematology & Oncology — Payments: $17,276
Hematology & Oncology $17,276
Dr. Atif Shafqat, M.d, M.D
Hematology & Oncology — Payments: $13,313
Hematology & Oncology $13,313
Dr. Shabbir Safdar, M.d, M.D
Hematology & Oncology — Payments: $12,290
Hematology & Oncology $12,290